Special Issue "Biofilms from Fermentative Perspective: Structures, Functions and Control 2.0"

A special issue of Fermentation (ISSN 2311-5637). This special issue belongs to the section "Microbial Metabolism, Physiology & Genetics".

Deadline for manuscript submissions: 30 June 2023 | Viewed by 1702

Special Issue Editor

Department of Microbiology and Virology, Medical Institute, Peoples’ Friendship University of Russia, Moscow, Russia
Interests: biofilms; yeast biotechnology; candida; yeast adhesins; yeast systems biology; nanobiotechnology; optical density; quorum sensing
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In nature, as a rule, several types of microorganisms coexist in biofilms in the form of a single community. It is shown that in a biofilm, in comparison with pure planktonic cultures of bacteria, their numerous physiological processes occur in a different way, including the production of metabolites and biologically active substances. Microbial biofilms comprises of major classes of macromolecules like nucleic acids, polysaccharides, proteins, enzymes, lipids, humic substances as well as ions. The presence of these components indeed makes them resilient and enables them to survive hostile conditions.

The goal of this Special Issue is to publish both recent innovative research results, as well as review papers on the production of biofilms and fermentative processes of the biofilms. Review and research papers on development of novel enzymes and microbial strains are also of interest. If you would like to contribute a review paper, please contact one of the editors to discuss the topic relevance before submitting the manuscript.

This is 2.0 version of special issue, the original one can be viewed here:

https://www.mdpi.com/journal/fermentation/special_issues/biofilm_ferment

Dr. Nadezhda Sachivkina
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Fermentation is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bacterial biofilms 
  • antibiotic resistance 
  • therapeutic approaches
  • bacterial and fungi enzymes 
  • yeast protein structural biology
  • quorum sensing molecules

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Probiotic-Bacteria (Lactobacillus fermentum)-Wrapped Zinc Oxide Nanoparticles: Biosynthesis, Characterization, and Antibacterial Activity
Fermentation 2023, 9(5), 413; https://doi.org/10.3390/fermentation9050413 - 26 Apr 2023
Viewed by 543
Abstract
Recently, fabricated nanoparticles (NPs), which can efficiently penetrate biological systems, have found increased usage in the health and hygiene industries. Microbial enzymes and proteins have recently shown their potential to act as reducing agents for the production of NPs, thereby providing an alternative [...] Read more.
Recently, fabricated nanoparticles (NPs), which can efficiently penetrate biological systems, have found increased usage in the health and hygiene industries. Microbial enzymes and proteins have recently shown their potential to act as reducing agents for the production of NPs, thereby providing an alternative to physical and chemical methods. Not only is this approach efficient and cost-effective, but it also produces a minimal ecological footprint. In this study, zinc oxide nanoparticles (ZnO NPs) were synthesized using probiotic bacteria (Lactobacillus fermentum) as the reducing and capping agent. Several analytical methods, including Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), X-ray diffraction analysis (XRD), ultraviolet–visible spectroscopy (UV–Vis), and atomic force microscopy (AFM), were used to analyze the produced ZnO NPs. The SEM analysis confirmed the spherical form of the nanoparticles and estimated their average size to be between 100 and 120 nm. FT-IR analysis verified that the ZnO NPs’ surfaces contained many functional groups. X-ray diffraction examination evidenced that the biogenically produced nanoparticles were crystalline. AFM analysis revealed that the nanoparticles’ size was about 90–100 nm. The maximum absorption peak, determined via a UV–visible spectrophotometer, was 510 nm. The synthesized ZnO NPs’ antimicrobial activity against various bacterial strains was tested, and the highest level of antimicrobial activity was noted against a Vibrio harveyi strain. The maximum concentration, namely, 20 mM of ZnO NPs, showed the highest antimicrobial activity. These observations indicate that the synthesized ZnO NPs possess remarkable antimicrobial potency. This method is an efficient, environmentally friendly, cost-effective approach for producing ZnO NPs that are useful for various biomedical applications. Full article
Show Figures

Figure 1

Article
Green Synthesis of Copper Oxide Nanoparticles Using Sesbania grandiflora Leaf Extract and Their Evaluation of Anti-Diabetic, Cytotoxic, Anti-Microbial, and Anti-Inflammatory Properties in an In-Vitro Approach
Fermentation 2023, 9(4), 332; https://doi.org/10.3390/fermentation9040332 - 27 Mar 2023
Viewed by 899
Abstract
Green methods of synthesizing nanoparticles are safer than chemical and physical methods, as well as being eco-friendly and cost-efficient. In this study, we use copper oxide nanoparticles (CuO NPs) fabricated with Sesbania grandiflora (Sg) (Hummingbird tree) leaves to test the effectiveness of green [...] Read more.
Green methods of synthesizing nanoparticles are safer than chemical and physical methods, as well as being eco-friendly and cost-efficient. In this study, we use copper oxide nanoparticles (CuO NPs) fabricated with Sesbania grandiflora (Sg) (Hummingbird tree) leaves to test the effectiveness of green synthesizing methods. The attained Sg-CuO NPs physical and optical nature is characterized by UV-Vis spectroscopy Differential Reflectance Spectroscopy (UV-Vis DRS), Fourier Transform Infra-Red spectroscopy (FTIR), X-ray Diffraction spectroscopy (XRD), Scanning Electron Microscope (SEM), and Energy Dispersive X-ray Analysis (EDAX). UV-Vis spectrum for Sg-CuO NPs revealed a peak at 410 nm. SEM images showed the aggregation of needle-shaped particles, at a size of 33 nm. The amylase and glucosidase enzymes were inhibited by the Sg-CuO NPs up to 76.7% and 72.1%, respectively, indicating a possible antihyperglycemic effect. Fabricated Sg-CuO NPs disclosed the excellent inhibition of DPPH-free radicle formation (89.7%) and repressed protein degradation (81.3%). The results showed that Sg-CuO NPs display good anti-bacterial activity against the gram-negative (Escherichia coli and Pseudomonas aeruginosa) and gram-positive (Staphylococcus aureus). Cytotoxicity of the Sg-CuO NPs was determined using anIC50 of 37 μg/mL. Sg-CuO NPs have shown promising anti-diabetic, anti-oxidant, protein degradation-inhibiting, and anti-microbial properties. Our findings have shown that synthesized Sg-CuO NPs have biological activities that may be utilized to treat bacterial infections linked to hyperglycemia. Full article
Show Figures

Figure 1

Back to TopTop